Complement control for COVID-19
Markus Bosmann
Abstract
Excessive complement activation contributes to lung disease and adverse patient outcomes in COVID-19 (see the related research articles by Yan et al . and Ma et al . ).
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Complement (music)Complement system2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyCoronavirus InfectionsDiseasePneumoniaAdverse effectLungVirologyMedicineBiologyAntibodyInfectious disease (medical specialty)PathologyInternal medicineOutbreakGeneticsComplementationPhenotypeGeneComplement system in diseasesSARS-CoV-2 and COVID-19 ResearchCOVID-19 Impact on Reproduction